Control Bionics (ASX: CBL) Share Price

CBL

$0.09▲+3.45%

$28.7MRank #1181 on ASXHealthcareMedical - Devices

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$28.7M

Volume

844K

P/E Ratio

-1.4

EPS

-$0.0109

Dividend Yield

0.00%

52-Week High

$0.095

52-Week Low

$0.026

Beta

0.108

Control Bionics (ASX: CBL) is an Australian-listed company in the Healthcare sector with a market capitalisation of $28.7M and the 1181st-largest security on the ASX by market capitalisation. The CBL share price is $0.09, up 3.45% today and up 200.00% over the past 12 months. Shares have traded between $0.026 and $0.095 over the past 52 weeks. In its most recent reported period (ending 31 Dec 2025), Control Bionics reported revenue of $2.8M and a net loss of $3.6M.

Charts

$0.09

24H Range

$0.087

$0.095

52-Week Range

$0.026

$0.095

About Control Bionics Limited

Operating in Australia and North America, Control Bionics Limited and its subsidiaries specialize in the innovation, development, and market introduction of sophisticated assistive communication technologies. The company's offerings include the NeuroNode Trilogy and NeuroNode3 systems, which empower individuals facing speech and mobility challenges to control computers for speech generation, electronic correspondence, leisure activities, and remote operation of other devices. Control Bionics also provides Cosmos Connect, a versatile interface capable of managing diverse equipment like wheelchairs, robotic dining aids, and gaming consoles. Additionally, they offer Uno Touch, a dedicated speech-generating device, alongside various other sensors for a broad spectrum of uses. Founded in 2005, the entity was initially named Control Bionics Holdings Pty Limited before rebranding as Control Bionics Limited in September 2020. The company's base of operations is situated in Camberwell, Australia.

IPO Date

6 Dec 2020

CEO

Jeremy E. Steele

Employees

Website

controlbionics.com

Key Financial Data

Revenue (Quarterly)	$2.8M
Net Income (Quarterly)	$-3.6M
Total Assets	$9.9M
Total Debt	$258,099
Free Cash Flow	$-2.4M
Return on Equity	-46.70%
Profit Margin	-127.98%
Operating Margin	-123.18%

CBL Frequently Asked Questions

What is the Control Bionics (ASX: CBL) share price?

The CBL share price is $0.09, up 3.45% for the day, based on the latest available ASX market data.

What is Control Bionics's market capitalisation?

Control Bionics has a market capitalisation of $28.7M, making it the 1181st-largest security listed on the ASX.

Does Control Bionics pay a dividend?

CBL does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Control Bionics profitable?

In its most recent reported period (ending 31 Dec 2025), CBL reported revenue of $2.8M and a net loss of $3.6M.

How many CBL shares are on issue?

Control Bionics has approximately 319,403,156 shares on issue, based on its market capitalisation of $28.7M and current share price.

What sector is Control Bionics in?

Control Bionics is classified in the Healthcare sector, within the Medical - Devices industry on the ASX.

When did Control Bionics list on the ASX?

Control Bionics listed on the Australian Securities Exchange on 6 Dec 2020.

Latest News

Why Control Bionics (ASX:CBL) Shares Are Trading Higher on Thursday?

Kalkine4 June 2026

Why Control Bionics (ASX:CBL) Shares Are Trading Higher on Thursday? Kalkine

Inside Biotech: Neurotech moves from research labs to real-world healthcare

Proactive financial news4 June 2026

Inside Biotech: Neurotech moves from research labs to real-world healthcare Proactive financial news

Insights: Control Bionics Ltd (ASX:CBL)

smallcaps.com.au30 Oct 2025

Insights: Control Bionics Ltd (ASX:CBL) smallcaps.com.au

CBL:ASX Announcement - PRC-Saltillo - Distribution Agreement - 29 Jan 2026

Market Index29 Jan 2026

CBL:ASX Announcement - PRC-Saltillo - Distribution Agreement - 29 Jan 2026 Market Index

Biocurious: Control Bionics says outwitting the world’s richest man is a no-brainer

Stockhead8 Oct 2025

Biocurious: Control Bionics says outwitting the world’s richest man is a no-brainer Stockhead

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
IMEImExHS Limited	$20.9M	$0.385	44.16	0.00%	–+0.00%
PABPatrys Limited	$14.7M	$0.043	-0.62	0.00%	▲+2.38%
NTINeurotech International Limited	$13.1M	$0.013	-5.30	0.00%	▲+8.33%
TRUTruScreen Group Limited	$11.3M	$0.016	-2.37	0.00%	▲+6.67%
ICRIntelicare Holdings Limited	$10.9M	$0.023	0.00	0.00%	▼-2.13%
BGTBio-Gene Technology Limited	$5.9M	$0.022	-1.25	0.00%	▲+10.00%
PERPercheron Therapeutics Limited	$4.5M	$0.004	-0.79	0.00%	▼-11.11%
ADRAdherium Limited	$3.9M	$0.002	-0.50	0.00%	–+0.00%

ETFs That Hold CBL

CBL is held by 2 ASX-listed funds tracked on this site. The largest allocation is in Vanguard MSCI International Small Companies Index ETF (ASX: VISM) at 0.01% of its portfolio.

Fund	Portfolio Weight	Fund Size
VISMVanguard MSCI International Small Companies Index ETF	0.01%	$906.8M
VTSVanguard U.S. Total Market Shares Index ETF	0.00%	$9.53B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.088	$0.095	$0.087	$0.09	844K	▲+3.45%
11 June 2026	$0.082	$0.088	$0.082	$0.087	1.1M	▲+6.10%
10 June 2026	$0.075	$0.082	$0.072	$0.082	2.2M	▲+9.33%
9 June 2026	$0.08	$0.08	$0.075	$0.075	1.8M	▼-5.06%
8 June 2026	$0.074	$0.08	$0.07	$0.079	2.6M	–+0.00%
5 June 2026	$0.074	$0.08	$0.07	$0.079	2.6M	▲+11.27%
4 June 2026	$0.067	$0.075	$0.066	$0.071	6.2M	▲+20.34%
3 June 2026	$0.059	$0.059	$0.059	$0.059	745	–+0.00%
2 June 2026	$0.061	$0.061	$0.058	$0.059	186K	–+0.00%
1 June 2026	$0.061	$0.061	$0.058	$0.059	186K	▲+3.51%
29 May 2026	$0.057	$0.057	$0.057	$0.057	237K	▲+3.64%
28 May 2026	$0.056	$0.056	$0.055	$0.055	520K	▼-8.33%
27 May 2026	$0.06	$0.06	$0.06	$0.06	252K	–+0.00%
26 May 2026	$0.06	$0.06	$0.06	$0.06	252K	–+0.00%
25 May 2026	$0.06	$0.061	$0.06	$0.06	750K	▲+7.14%
22 May 2026	$0.06	$0.06	$0.056	$0.056	86K	▼-6.67%
21 May 2026	$0.06	$0.06	$0.06	$0.06	3.3K	–+0.00%
20 May 2026	$0.06	$0.06	$0.06	$0.06	191K	–+0.00%
19 May 2026	$0.06	$0.06	$0.06	$0.06	1.7K	▼-1.64%
18 May 2026	$0.061	$0.062	$0.061	$0.061	117K	▼-4.69%
15 May 2026	$0.064	$0.064	$0.064	$0.064	181K	▼-1.54%
14 May 2026	$0.063	$0.065	$0.063	$0.065	73K	▲+3.17%
13 May 2026	$0.066	$0.066	$0.063	$0.063	264K	▼-3.08%
12 May 2026	$0.07	$0.071	$0.065	$0.065	1.2M	▼-7.14%
11 May 2026	$0.068	$0.07	$0.068	$0.07	848K	▲+2.94%
8 May 2026	$0.065	$0.068	$0.065	$0.068	232K	▲+1.49%
7 May 2026	$0.069	$0.069	$0.065	$0.067	175K	▲+3.08%
6 May 2026	$0.062	$0.067	$0.062	$0.065	991K	–+0.00%
5 May 2026	$0.056	$0.065	$0.056	$0.065	1.1M	▲+16.07%
4 May 2026	$0.057	$0.057	$0.056	$0.056	175K	–+0.00%

About Control Bionics Limited

IPO Date

6 Dec 2020

CEO

Jeremy E. Steele

Employees

Website

controlbionics.com

CBL Frequently Asked Questions

What is the Control Bionics (ASX: CBL) share price?

The CBL share price is $0.09, up 3.45% for the day, based on the latest available ASX market data.

What is Control Bionics's market capitalisation?

Control Bionics has a market capitalisation of $28.7M, making it the 1181st-largest security listed on the ASX.

Does Control Bionics pay a dividend?

CBL does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Control Bionics profitable?

In its most recent reported period (ending 31 Dec 2025), CBL reported revenue of $2.8M and a net loss of $3.6M.

How many CBL shares are on issue?

Control Bionics has approximately 319,403,156 shares on issue, based on its market capitalisation of $28.7M and current share price.

What sector is Control Bionics in?

Control Bionics is classified in the Healthcare sector, within the Medical - Devices industry on the ASX.

When did Control Bionics list on the ASX?

Control Bionics listed on the Australian Securities Exchange on 6 Dec 2020.

Company

Market Cap

Price

P/E

Div Yield

1D Change

IMEImExHS Limited

$20.9M

$0.385

44.16

0.00%

–+0.00%

PABPatrys Limited

$14.7M

$0.043

-0.62

0.00%

▲+2.38%

NTINeurotech International Limited

$13.1M

$0.013

-5.30

0.00%

▲+8.33%

TRUTruScreen Group Limited

$11.3M

$0.016

-2.37

0.00%

▲+6.67%

ICRIntelicare Holdings Limited

$10.9M

$0.023

0.00

0.00%

▼-2.13%

BGTBio-Gene Technology Limited

$5.9M

$0.022

-1.25

0.00%

▲+10.00%

PERPercheron Therapeutics Limited

$4.5M

$0.004

-0.79

0.00%

▼-11.11%

ADRAdherium Limited

$3.9M

$0.002

-0.50

0.00%

–+0.00%

ETFs That Hold CBL

CBL is held by 2 ASX-listed funds tracked on this site. The largest allocation is in Vanguard MSCI International Small Companies Index ETF (ASX: VISM) at 0.01% of its portfolio.

Fund

Portfolio Weight

Fund Size

VISMVanguard MSCI International Small Companies Index ETF

0.01%

$906.8M

VTSVanguard U.S. Total Market Shares Index ETF

0.00%

$9.53B

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$0.088	$0.095	$0.087	$0.09	844K	▲+3.45%
11 June 2026	$0.082	$0.088	$0.082	$0.087	1.1M	▲+6.10%
10 June 2026	$0.075	$0.082	$0.072	$0.082	2.2M	▲+9.33%
9 June 2026	$0.08	$0.08	$0.075	$0.075	1.8M	▼-5.06%
8 June 2026	$0.074	$0.08	$0.07	$0.079	2.6M	–+0.00%
5 June 2026	$0.074	$0.08	$0.07	$0.079	2.6M	▲+11.27%
4 June 2026	$0.067	$0.075	$0.066	$0.071	6.2M	▲+20.34%
3 June 2026	$0.059	$0.059	$0.059	$0.059	745	–+0.00%
2 June 2026	$0.061	$0.061	$0.058	$0.059	186K	–+0.00%
1 June 2026	$0.061	$0.061	$0.058	$0.059	186K	▲+3.51%
29 May 2026	$0.057	$0.057	$0.057	$0.057	237K	▲+3.64%
28 May 2026	$0.056	$0.056	$0.055	$0.055	520K	▼-8.33%
27 May 2026	$0.06	$0.06	$0.06	$0.06	252K	–+0.00%
26 May 2026	$0.06	$0.06	$0.06	$0.06	252K	–+0.00%
25 May 2026	$0.06	$0.061	$0.06	$0.06	750K	▲+7.14%
22 May 2026	$0.06	$0.06	$0.056	$0.056	86K	▼-6.67%
21 May 2026	$0.06	$0.06	$0.06	$0.06	3.3K	–+0.00%
20 May 2026	$0.06	$0.06	$0.06	$0.06	191K	–+0.00%
19 May 2026	$0.06	$0.06	$0.06	$0.06	1.7K	▼-1.64%
18 May 2026	$0.061	$0.062	$0.061	$0.061	117K	▼-4.69%
15 May 2026	$0.064	$0.064	$0.064	$0.064	181K	▼-1.54%
14 May 2026	$0.063	$0.065	$0.063	$0.065	73K	▲+3.17%
13 May 2026	$0.066	$0.066	$0.063	$0.063	264K	▼-3.08%
12 May 2026	$0.07	$0.071	$0.065	$0.065	1.2M	▼-7.14%
11 May 2026	$0.068	$0.07	$0.068	$0.07	848K	▲+2.94%
8 May 2026	$0.065	$0.068	$0.065	$0.068	232K	▲+1.49%
7 May 2026	$0.069	$0.069	$0.065	$0.067	175K	▲+3.08%
6 May 2026	$0.062	$0.067	$0.062	$0.065	991K	–+0.00%
5 May 2026	$0.056	$0.065	$0.056	$0.065	1.1M	▲+16.07%
4 May 2026	$0.057	$0.057	$0.056	$0.056	175K	–+0.00%